Product image
InVivoMAb anti-mouse CD103
BE0026
ApplicationsFlow Cytometry, ImmunoFluorescence, Neutralisation/Blocking
Product group Antibodies
ReactivityMouse
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse CD103
- Delivery Days Customer7
- ApplicationsFlow Cytometry, ImmunoFluorescence, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDM290
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostRat
- IsotypeIgG2a
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells. Liikanen I et al., 2021 Apr 1, J Clin InvestRead more
- Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells. Homet Moreno B et al., 2016 Oct, Cancer Immunol ResRead more
- Efficient elimination of CD103-expressing cells by anti-CD103 antibody drug conjugates in immunocompetent mice. Mang Y et al., 2015 Jan, Int ImmunopharmacolRead more
- Foxp3+ regulatory T cells promote lung epithelial proliferation. Mock JR et al., 2014 Nov, Mucosal ImmunolRead more
- Mucosal imprinting of vaccine-induced CD8+ T cells is crucial to inhibit the growth of mucosal tumors. Sandoval F et al., 2013 Feb 13, Sci Transl MedRead more